Brief: Prime Medicine, Inc. Q3 EPS USD -0.55
03/11/2023 20:01
Nov 3 (Reuters) - Prime Medicine, Inc. Q3 EPS USD -0.55. * Q3 net income USD -50.708 million * Q3 pretax profit USD -50.816 million * Q3 operating expenses USD 51.459 million * Q3 income from operations USD -51.459 million
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease